Eramet S.a.
ERMAY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $2 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $3 | $3 | $3 | $3 |
| Revenue | $3 | $3 | $5 | $4 |
| % Growth | -12.2% | -33.4% | 35.1% | – |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 58.4% | 59.9% | 24.6% | 20.5% |
| EBITDA | $0 | $0 | $1 | $1 |
| % Margin | 16% | 7.3% | 26.4% | 31% |
| Net Income | $0 | $0 | $1 | $0 |
| % Margin | 0.5% | 3.3% | 14.8% | 8% |
| EPS Diluted | 0.05 | 0.36 | 2.55 | 1.04 |
| % Growth | -86.1% | -85.9% | 145.2% | – |
| Operating Cash Flow | -$0 | $0 | $1 | $1 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$1 | -$0 | $0 | $0 |